Exicure
XCUR | NASDAQ
$1.07
-$0.01 (-0.93%)
At close: Nov 16, 2026, 4:00 PM ET
$1.12
+$0.05 (+4.67%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.93%
(1D)No price chart data available for 1D timeframe.
Rating
33.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #694/1021 (Top 68%)
Key Statistics
Market Data
Market Cap $7M
1D Range
1.00 1.11
52W Range
0.89 7.29
Valuation (TTM)
PE -0.82
PB 7.17
EV/EBITDA -0.62
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $12.00
Cash Flow
FCF Yield -91.2%
SBC Adj. FCF Yield -91.2%
SBC Impact 0.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-55.4%
Dil EPS 3Y | 5Y -15.3% |
74.2%
FCF 3Y | 5Y -24.2% |
48.3%
Returns
ROA -72.7%
ROE -237.9%
ROIC -93.9%
Financial Health
Net Cash
$1.72M
Current Ratio 0.56
Interest Coverage -7,304.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development a...
Sector Healthcare
Industry Biotechnology
Employees 1
IPO Date May 22, 2018
Website www.exicuretx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove XCUR